SEC Comment Letter 0000000000-24-003573 to Dare Bioscience, Inc. (DARE) (CIK 0001401914) (DARE)
Dare Bioscience, Inc. (DARE) (CIK 0001401914)
Date: April 3, 2024 · CIK: 0001401914 · Accession: 0000000000-24-003573
AI Filing Summary & Sentiment
File numbers found in text: 333-278378
Letter
United States securities and exchange commission logo April 3, 2024 MarDee Haring-Layton Chief Accounting Officer Daré Bioscience, Inc. 3655 Nobel Drive, Suite 260 San Diego, California 92122 Re:Daré Bioscience, Inc. Registration Statement on Form S-3 Filed March 29, 2024 File No. 333-278378 Dear MarDee Haring-Layton: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jessica Zhang, Esq.
Show Raw Text
United States securities and exchange commission logo
April 3, 2024
MarDee Haring-Layton
Chief Accounting Officer
Daré Bioscience, Inc.
3655 Nobel Drive, Suite 260
San Diego, California 92122
Re:Daré Bioscience, Inc.
Registration Statement on Form S-3
Filed March 29, 2024
File No. 333-278378
Dear MarDee Haring-Layton:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Jessica Zhang, Esq.